Ophthalmology Prior Authorization: How AI Cuts Procedure Approval Delays

Ophthalmology has a prior authorization problem that compounds differently than most specialties. A rheumatology practice might submit one prior auth for a biologic infusion that covers 12 months of treatment. An ophthalmology practice treating the same patient with anti-VEGF injections every four to eight weeks needs to reauthorize that treatment on a rolling cycle – typically every six months.

For a practice treating 200 active wet macular degeneration patients, those reauthorization cycles alone generate roughly 400 prior authorization submissions per year from that single diagnosis group. Add cataract surgery documentation requirements, blepharoplasty functional impairment evidence, and glaucoma procedure authorizations, and you have a prior auth workload that does not match how most practices staff their billing and administrative teams.

AI is reducing that workload by handling the structured, repeatable parts of the authorization workflow: gathering documentation, checking payer requirements, submitting requests, and managing follow-up. Staff still handle exceptions and appeals. The difference is they are not also handling the routine submissions.

The anti-VEGF authorization cycle

Anti-VEGF injections for conditions like neovascular age-related macular degeneration, diabetic macular edema, and retinal vein occlusion are among the highest-volume prior authorization requests in any ophthalmology practice. The drugs in this class – ranibizumab, aflibercept, bevacizumab, and the newer faricimab – are often used on loading dose schedules followed by ongoing maintenance dosing at intervals determined by clinical response.

The authorization challenge is that many payers require re-authorization at intervals that do not align with treatment frequency. A patient receiving injections every four to eight weeks – depending on loading versus maintenance phase – may need a new prior authorization every six months. That authorization requires updated visual acuity documentation, OCT scan findings, and documentation that the treatment is producing clinical benefit.

For a practice using bevacizumab (Avastin) – the off-label but widely used and significantly less expensive agent – some payers require step therapy documentation showing bevacizumab was tried before authorizing branded agents. That documentation requirement adds another layer to the authorization submission for patients who are switching agents or for new patients whose history must be gathered.

AI handles the repeating authorization workflow by pulling the required documentation from athenahealth at the start of each authorization cycle: current visual acuity, most recent OCT findings, prior treatment history, and the specific payer’s step therapy requirements. The submission package gets assembled from the patient record rather than requiring staff to manually gather the same set of documents for each renewal.

Cataract surgery: documenting medical necessity

Cataract surgery prior authorization requirements vary by payer, but most commercial payers and Medicare Advantage plans require documentation of:

• Best corrected visual acuity below a threshold (commonly 20/40 or worse in the operative eye)
• Impact on daily activities or functional vision
• Failure of conservative management or documentation that no conservative alternative applies

The documentation for cataract surgery is not complex, but it must be precise. A payer that requires documentation of functional impairment needs more than a visual acuity number. They need documentation that the patient cannot drive safely, has difficulty reading, or has other specific functional limitations that the surgical correction will address.

Ophthalmology practices that do high cataract volume – 10 to 20 cases per week is common for a busy surgical practice – spend significant staff time assembling and submitting this documentation for every case. When a case is scheduled three to four weeks out and the authorization request is not submitted promptly, the practice risks the authorization arriving after the scheduled date or requiring expedited review.

AI monitors the surgical schedule and initiates authorization requests as soon as a case is booked. It pulls the required documentation from athenahealth, checks the specific payer’s documentation requirements, and flags any missing elements before submission. Staff review the flagged cases rather than working through every authorization from scratch.

Blepharoplasty: the functional vs. cosmetic distinction

Blepharoplasty is one of the more documentation-intensive authorizations in ophthalmology because payers require clear evidence of functional impairment rather than cosmetic motivation.

For upper eyelid blepharoplasty covered under medical benefits, payers typically require:

• Visual field testing showing superior visual field defect caused by the ptotic lid
• Photographs demonstrating the lid position
• Documentation of how the visual field defect affects daily function
• Provider notes explaining the clinical basis for surgical correction

A payer that receives documentation without the visual field testing or photographs will deny the request, requiring resubmission. The resubmission process adds two to three weeks to the authorization timeline and may delay a patient’s surgical date.

AI manages this by checking the required documentation checklist before the authorization request goes out. For blepharoplasty, it verifies that visual field results are in the record, that photographs have been uploaded, and that the clinical notes include functional impairment language that matches the payer’s requirements. Incomplete submissions get flagged before they leave the practice, not after a denial comes back.

Glaucoma procedure authorizations

Glaucoma procedures – including selective laser trabeculoplasty (SLT), trabeculectomy, minimally invasive glaucoma surgery (MIGS), and tube shunt implantation – require prior authorization from most commercial payers.

The documentation requirements for glaucoma procedures typically include:

• Intraocular pressure measurements and trends
• Optic nerve imaging showing damage progression
• Documentation of medical therapy trials and response
• Visual field testing showing documented field loss

For MIGS procedures specifically, some payers require documentation that the procedure is being performed in conjunction with cataract surgery, or that specific IOP thresholds have been met despite maximum tolerated medical therapy. The authorization requirements vary enough by procedure type and payer that staff handling glaucoma authorizations need to check payer-specific criteria for each submission.

AI handles this by pulling the relevant IOP history, optic nerve imaging, and medication trial documentation from athenahealth and matching it against the specific payer’s published authorization criteria. Where criteria are met, it submits. Where documentation gaps exist, it flags the case for staff review with a specific list of what is missing.

The timeline problem in high-volume surgical practices

The authorization timeline in ophthalmology creates operational pressure that practices with lower surgical volume do not face. When a busy ophthalmology practice schedules 15 cataract cases per week and each requires prior authorization, the practice needs a system that keeps authorizations ahead of the surgical schedule consistently.

A case booked for surgery in three weeks needs an authorization request submitted within the first few days of booking to allow time for the payer’s review period, any requests for additional information, and the return of the authorization before the case date. Practices that rely on staff to manually track the authorization queue against the surgical schedule frequently find cases approaching their surgical date without a confirmed authorization.

AI monitors the surgical schedule in real time and flags any case where the authorization has not been submitted within the practice’s target window after booking. It also tracks pending authorizations and follows up with payers when the review period has passed without a determination.

The practical effect is that cases are less likely to reach the operating room with a missing or expired authorization. Day-of case cancellations due to missing prior auth are among the most expensive administrative failures in a surgical ophthalmology practice – the operating room time is booked, the patient has prepared for surgery, and everyone involved absorbs the cost of the cancellation.

Handling denials and appeals

Prior authorization denials in ophthalmology are common, particularly for higher-cost agents and procedures where payers apply step therapy requirements. The denial management process – reviewing the denial reason, gathering additional documentation, and submitting the appeal – requires the same structured documentation gathering as the initial submission, plus an understanding of why the specific denial was issued.

AI handles the structured elements of denial management: pulling the denial reason, identifying what additional documentation the payer has requested, and assembling the appeal package from the patient record. Staff review and submit the appeal. For straightforward denials where the payer requests additional clinical documentation that is already in athenahealth, AI can have the appeal package ready for staff review within minutes of the denial arriving.

For peer-to-peer review requests – where the payer requests a conversation between their medical director and the treating physician – AI handles the scheduling and preparation: confirming the peer-to-peer appointment, pulling the clinical summary the physician needs, and logging the outcome in athenahealth.

What high-volume ophthalmology practices actually gain

The math for ophthalmology prior auth is straightforward. A practice submitting 200 authorizations per month at 20 minutes each for documentation gathering, submission, and follow-up is spending about 67 staff hours per month on the authorization workflow. At $25 per hour, that is $1,675 per month in labor, not counting the time spent on denials, appeals, and re-authorizations.

AI reduces the time per authorization for routine submissions by handling the document gathering and submission automatically. Staff time shifts from routine submission to exception handling: the cases where documentation is missing, where denials require clinical review, and where appeals need physician involvement.

For practices with high anti-VEGF volume, the compounding effect of reauthorization cycles means the time savings increase with practice size. A practice treating 300 active wet AMD patients is reauthorizing a large share of that population on a rolling six-month cycle. Automating that cycle changes the staffing equation for the authorization team.